Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Prednisone for Adrenal Crisis Prevention
NCT02689960Phase 2Completed
- Start
- Jan 2017
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, open-label trial of prednisone in adrenal insufficiency (AI) (2 arms). Primary endpoint: Bioequivalence of vaginal prednisone administration compared to rectal application up to 12 months. Started Jan 2017; status: completed.
02
Drugs
prednisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT02689960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689960.